Study of AST-001 for advanced solid tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial is testing a new drug called AST-001 for people with advanced solid tumors (including pancreatic cancer) that have not responded to standard treatments. The study aims to find the right dose and see how well the drug works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old
- You have advanced cancer that has spread or cannot be removed, and standard treatments are no longer working
- You are able to get around and take care of yourself (ECOG 0 or 1)
- Your cancer has been confirmed by a biopsy (tissue sample)
- You have recovered from side effects of your prior cancer treatments
- Your kidneys, liver, and blood counts are working well enough
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called FTL001 for people with advanced solid tumors that have not improved with standard therapy. The goal is to see if it is safe and how well it works.
This trial tests an experimental drug called RP-001 in people with advanced or metastatic cancer that has not improved with standard treatment. It aims to see if the drug is safe and how well it works.
This trial tests a new drug called AST-201 for people with advanced solid tumors that have a specific protein (GPC3). The study aims to see how safe and well-tolerated the drug is, and how the body processes it.
This early-phase trial tests a new drug (CD-001) for people with advanced solid tumors. It will check if the drug is safe, how the body handles it, and if it helps shrink tumors.
This trial tests a new drug called LAT010 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective.
This Phase 1/2 study tests two investigational medicines (PE0116 and PE0105) in people with advanced solid cancers that have spread or cannot be removed by surgery. It may help shrink tumors or slow disease when standard treatments have not worked or are not tolerated.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.